Skip to main content
Equibles
DOC logo

DOC · Healthpeak Properties, Inc. · Metrics

Track DOC — free

Use DOC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DOC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.16 -0.21 (-1.03%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$14.05B
Shares
689.53M

DOC metrics

76 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$20.37
Market cap
$14.05B

Price action

20 metrics
Price change (1W)
-1.4%
Price change (30D)
-1.0%
Price change (3M)
-0.3%
Price change (6M)
+17.3%
Price change (YTD)
+26.7%
Price change (1Y)
+12.7%
Trailing year
Price change (5Y)
-42.4%
52-week high
$22.82
52-week low
$15.78
Change from 52-week high
-10.7%
Change from 52-week low
+29.1%
Annualized volatility
29.2%
Annualized volatility (3M)
22.1%
Beta
0.4
RSI (14D)
37.9
Price vs SMA 50
-4.9%
Price vs SMA 200
+9.0%
Avg volume (3M)
5.72M
Relative volume
0.6
Average dollar volume
$122.12M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
689.53M

Valuation

12 metrics
P / E (TTM)
58.2
Trailing earnings · reciprocal yield 1.7%
PEG ratio
1.0
EV / revenue
7.6×
reciprocal yield 13.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
4.8×
reciprocal yield 21.0%
P / book
1.8
reciprocal yield 55.9%
FCF yield
—
TTM · current market cap
Buyback yield
0.7%
P / FCF
—
P / operating cash flow
11.4
reciprocal yield 8.8%
Earnings yield
1.7%

Historical valuation

8 metrics
P / E historical average (3Y)
61.8×
reciprocal yield 1.6%
P / E historical average (5Y)
50.0×
reciprocal yield 2.0%
EV / revenue historical average (3Y)
8.2×
reciprocal yield 12.2%
EV / revenue historical average (5Y)
9.2×
reciprocal yield 10.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
6.5%
Trailing 12 months
Payout ratio
347.7%
Shareholder yield
6.7%
Dividend / share (TTM)
$1.33
Dividend growth YoY
+18.9%
Dividend growth streak
1
Last ex-dividend
2026-09-14

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
8.2%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$243.30M
Trailing 12 months
Diluted EPS (TTM)
$0.35
FCF margin
—
Effective tax rate
0.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$10.79

Growth

11 metrics
Revenue growth YoY
+11.1%
Year over year
Net income growth YoY
+66.8%
Revenue (TTM)
$2.95B
Trailing 12 months
EPS growth YoY
+60.0%
Shares change YoY
-0.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+11.0%
Revenue CAGR (5Y)
+11.4%
EPS CAGR (3Y)
-52.3%
EPS CAGR (5Y)
-33.5%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
3.1%
Return on assets
1.1%
Debt / equity
1.3
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$8.41B
Latest balance sheet
Cash & equivalents
$1.63B
Total assets
$21.68B
Total debt
$10.03B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.23B
Capital expenditures (TTM)
$458.90M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$17.35M
R&D / revenue
—
Stock compensation / revenue
0.6%

Ownership (13F)

3 metrics
13F filers
759
13F filer change QoQ
+8
Institutional ownership
96.1%

Short interest

3 metrics
Short interest
3.5%
Latest settlement · 5.6 days to cover
Days to cover
5.6d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 765880 CUSIP 42250P103 13F (30d) 33 filings 31 filers Visit website Investor relations